The importance of early diagnosis in the neonatal period for group B Streptococcus
DOI:
https://doi.org/10.11606/issn.1679-9836.v102iespe-204159Keywords:
Group B Streptococcus, Streptococcus agalactiae, Pregnancy infectious, Neonatal sepsisAbstract
Streptococcus agalactiae or Group B Streptococcus (GBS) correspond to Gram positive diplococcus, usually residing in the microbiota of the gastrointestinal and genitourinary tract of pregnant women. The transmission of GBS occurs mainly through vertical ascent, especially in the intrapartum period, being one of the main bacteria responsible for the development of sepsis in the neonatal period. Early diagnosis associated with adequate antibiotic prophylaxis predicts lower risks of neonatal infection, in addition to a lower rate of complications and infant mortality. To carry out the research, we used high-impact articles taken from MEDLINE, SciELO, Pubmed, CNPq and LILACS platforms (2015–2022) and compiled a recent theoretical reference, with the exception of the historical reference, under which there was no time limitation. In reference to the levels of preventive medicine it can be observed: The primary prevention shows that the possibility of developing vaccines is viable, but so far in phase II in international studies and with a lack of epidemiological studies regarding the specific capsular serotypes of each Brazilian regions, hindering the development of the measure. Regarding the microbiological screening of GBS indicated by the Ministry of Health in 2012, it should be performed between the 35th and 37th week of pregnancy, in contrast to more recent international literature. In secondary prevention, there are new ways of diagnosing GBS infection, for example, the Xpert GBS, a rapid test indicated to test women at risk of preterm birth or in labor who did not undergo the test during prenatal care. The secondary still involves the existing treatment, which would be through the use of first-choice antimicrobials, such as crystalline penicillin or ampicillin, however, in some cases they already have resistance, requiring microbiological evaluation with antibiogram. In conclusion, the topic is extremely important for maternal and child health. GBS infection is a preventable disease with a simple diagnosis, however, there is still a huge literature divergence and lack of Brazilian protocols emphasizing the relevance of screening for GBS, which should be performed extensively in pregnant women, with antibiotic prophylaxis only in specific cases and, if necessary, with a previous sensitivity analysis to antimicrobials, in order to obtain better results.
Downloads
References
Cunningham FG, Leveno KJ, Bloom SL, Dashe JS, Hoffman BL, Caseu BM, et al. Williams obstetrics. 25ª ed. Mexico City: Mc Graw Hill Education; 2019. p.1209-34.
Boyer KM, Gadzala CA, Kelly PD, Gotoff SP. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. III. Interruption of mother-to-infant transmission. J Infect Dis. 1983;148(5):810-16. doi: https://doi.org/10.1093/infdis/148.5.810
Melo SCCS, Costa AB, Silva FTR, Silva NMMG, Tashima CM, Cardoso FR et al. Prevalence of Streptococcus agalactiae colonization in pregnant women from the 18th Health Region of Paraná State. J Inst Trop Med São Paulo. 2017;60:e2. doi: https://doi.org/10.1590/S1678-9946201860002
Nascimento CS. Streptococcus agalactiae – Serotypic distribution and relation with virulence factors and antimicrobial resistence [master’s degree]. São Paulo: Faculty of Pharmaceutical Science sat the University of São Paulo; 2019. doi: https://doi.org/10.11606/D.9.2019.tde-07062019-174324
American College of Obstetricians and Gynecologists. Prevention of Group B Spretococcal Early-Onset Disease in Newborns: ACOG Committee Opinion, Number 797. Obstetr Gynecol. 2020;135(2):e51-e72. doi: http://dx.doi.org/10.1097/aog.0000000000003668
Dzanibe S, Madhi SA. Systematic review of the clinical development of group B streptococcus serotype-specific capsular polysaccharide-based vaccines. Expert Rev Vaccines. 2018;17:635-51. doi: https://doi.org/10.1080/14760584.2018.1496021
Vojtek I, Dieussaert I, Doherty TM, Franck V, Hanssens L, Miller J, et al. Maternal immunization: where are we now and how to move forward? Ann Med. 2018;50(3):193-208. doi: 10.1080/07853890.2017.1421320
Zhang Y, Song L, Zhang S, Zhang S, Yu Y, Yao H, et al. Development and evaluation of a multi-epitope subunit vaccine against group B Streptococcus infection. Emerg Microbes Infect. 2022;11(1):2371-82. doi: https://dx.doi.org/10.1080/22221751.2022.2122585
World Health Organization. WHO Recommendations for prevention and treatment of maternal peripartum infection. Geneva: Human Reproduction Programme; 2015.
Xie ZY, Li YJ, Lei CR. Relationship between asymptomatic bacteriuria and vaginal colonization of Group B Streptococcus in the third trimester of pregnancy. Acta Acad Med Sinica. 2022;44(3):398-402. doi: 10.3881/j.issn.1000-503X.14368
Vieira LL, Perez AV, Machado MM, Kayser ML, Vettori DV, Alegretti AP, et al. Group B Streptococcus detection in pregnant women: comparison of qPCR assay culture, and the Xpert GBS rapid test. BMC Pregnancy Childbirth. 2019;19:532. doi: http://dx.doi.org/10.1186/s12884-019-2681-0.
Van Dyke MK, Phares CR, Lynfield R, Thomas AR, Arnold KE, Craig AS, et al. Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med. 2009;360 (25):2626-36. doi: 10.1056/NEJMoa0806820.
Collin SM, Demirjian A, Swann C, Lamagni T. Race and Ethnicity in Neonatl Group B Streptococcal disease in England: 2016-2020. Pediatrics. 2022;150(3):e2021056080. doi: https://doi.org/10.1542/peds.2021-056080
Collins A, Weitkamp JH, Wynn JL. Why are preterm newborns at increased risk of infection? Arch Dis Child Fetal Neonatal Ed. 2018;103(4):391-94. doi: http://dx.doi.org/10.1136/archdischild-2017-313595
Heinsen SM, Souza IF, Maikot SCV, Silva AP, Fedatto PF, Gomes ACM. Profile of pregnant women colonized by group B Streptococcus served by the unique health system in a laboratory of Medianeira Paraná. Int Res J Obstet Gynecol. 2021;4:38. https://escipub.com/Articles/IRJOG/IRJOG-2021-05-1806.pdf
Oliveira TVL, Santana FAF, Souza CL, Oliveira MV. Prevalence and factors associated with colonization by group B streptococcus in pregnant women. Rev Bras Saude Mater Infant. 2020;20(4):1173-80. https://doi.org/10.1590/1806-93042020000400013
Yow MD, Mason EO, Leeds LJ, et. al. Ampicillin prevents intrapartum transmission of group B streptococcus. JAMA. 1979;241(12):1245-47. doi: https://doi.org/10.1001/jama.1979.03290380021019.
Berardi A, Pietrangiolillo Z, Reggiani MLB, Bianco V, Gallesi D, Rossi K, et al. Are postnatal ampicillin levels actually related to the duration of intrapartum antibiotic prophylaxis prior to delivery? A pharmacokinetic study in 120 neonates. Arch Dis Child Fetal Neonatal Ed. 2018;103(2):F152-F256. doi: 10.1136/archdischild-2016-312546e
Barber EL, Zhao G, Buhimschi IA, Illuzzi JL. Duration of intrapartum prophylaxis and concentration of penicillin G in fetal serum at delivery. Obstet Gynecol. 2008;112(2 Pt 1):265-70. doi: 10.1097/AOG.0b013e31817d0246.
De Cueto M, Sanchez MJ, Sampedro A, Miranda JA, Herruzo AJ, Rosa-Fraille M. Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus. Obstet Gynecol. 1998;91(1):112-14. doi: 10.1016/s0029-7844(97)00587-5.
Brazil. Ministry of Health. Elaboration Guide: Scope for Clinical Protocols and Therapeutic Guidelines. Brasília, DF: Ministry of Health; 2019.
Brazil. Ministry of Health. Pregnancy Handbook. Brasília, DF: Ministry of Health; 2018.
Brazil. Ministry of Health. Basic Care book: Low-risk prenatal care. Brasília, DF: Publisher of the Ministry of Health; 2013.
Brazil. Ministry of Health. High-risk pregnancy: Technical Manual. Brasília, DF: Publisher of the Ministry of Health; 2012.
American Academy of Pediatrics - Comite Committee on Fetus and Newborn, Committee on Infectious Diseases. Management of Infants at Risk for Group B Streptococcal Disease. Pediatrics. 2019;144(2):e20191881. doi: https://doi.org/10.1542/peds.2019-1881
Procianoy RS, Silveira RC. The Challenges of neonatal sepsis managment. J Pediatria. 2020;96(S1):80-86. doi: http://dx.doi.org/10.1016/j.jped.2019.10.004
American Academy of Pediatrics - Committee on Fetus and Newborn, Committee on Infectious Diseases. Management of Neonates Born at ≥35 0/7 Weeks’ Gestation with Suspected or Proven Early-Onset Bacterial Sepsis. Pediatrics. 2018;142(6):e20182894. doi: https://doi.org/10.1542/peds.2018-2894
São Paulo City Hall, Epidemiology and Information Coordination. Adolescent pregnancy in the city of São Paulo: 2013 to 2017. CEInfo Analysis Bull. 2019;14(16).
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Débora Lais Justo Jacomini, Heloisa Beraldi Murayama
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.